Lumos Pharma Inc is categorized under Research and Development Laboratories in Austin, TX and active since 2014.
Lumos Pharma Inc was established in 2014, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Research and Development Laboratories business, which does work in the B2B market, and is classified as a Research and Development Laboratories, under code number 541712 by the NAICS.
If you are seeking more information, feel free to contact Richard J Hawkins at the company’s single location by writing to 515 Congress Avenue # 1800, Austin, Texas TX 78701 or by phoning (512) 327-9530. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Lumos Pharma Inc |
| Contact Person: | Richard J Hawkins |
| Address: | 515 Congress Avenue # 1800, Austin, Texas 78701 |
| Phone Number: | (512) 327-9530 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2014 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Research and Development Laboratories |
| SIC Code: | 8731 |
| NAICS Code: | 541712 |
| Share This Business: |
Lumos Pharma Inc was started in 2014 to provide professional Research and Development Laboratories under the SIC code 8731 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Richard J Hawkins for inquiries that concern Lumos Pharma Inc by calling the company number (512) 327-9530, as your correspondence is most welcome. Additionally, the physical location of the single location of Lumos Pharma Inc can be found at the coordinates 30.267879,-97.742724 as well as the street address 515 Congress Avenue # 1800 in Austin, Texas 78701.
For its online presence, you may visit Lumos Pharma Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.